Home/Filings/4/0001209191-13-041525
4//SEC Filing

SOPHIRIS BIO INC. 4

Accession 0001209191-13-041525

CIK 0001563855operating

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 3:41 PM ET

Size

4.8 KB

Accession

0001209191-13-041525

Insider Transaction Report

Form 4
Period: 2013-08-20
Slover Peter T
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2013-08-20$4.25/sh+4,680$19,8674,680 total
Footnotes (1)
  • [F1]The weighted average sales price for the transaction reported was $4.245, and the range of prices were between $4.22 and $4.25. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Issuer

SOPHIRIS BIO INC.

CIK 0001563855

Entity typeoperating
IncorporatedBritish Columbia, Canada

Related Parties

1
  • filerCIK 0001563855

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 3:41 PM ET
Size
4.8 KB